Inactive Instrument
ARYx Therapeutics, Inc. Share Price Other OTC
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 90.35L 78.45L 73.14L 67.19L 1.27Cr 86Cr 1.28Cr 8.62Cr 3.37Cr 43Cr 3.39Cr 3.32Cr 142.35Cr | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 1.14Cr 99.04L 92.34L 84.83L 1.6Cr 108.49Cr 1.62Cr 11Cr 4.26Cr 54Cr 4.28Cr 4.19Cr 179.7Cr | EV / Sales 2008 |
40,19,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +47.06% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +47.06% | +4.62% | - | - | 33 | |
| +10.00% | +14.90% | +53.89% | +87.07% | 6.25TCr | |
| +1.13% | -5.05% | +22.94% | +66.57% | 5.24TCr | |
| -0.98% | -1.19% | -16.98% | -14.21% | 2.31TCr | |
| +0.30% | -5.17% | -11.23% | +349.07% | 2.14TCr | |
| -0.31% | +0.40% | +30.99% | -26.23% | 1.78TCr | |
| +4.29% | +8.97% | +200.03% | +341.85% | 1.55TCr | |
| +1.12% | -1.93% | +12.70% | +607.25% | 1.47TCr | |
| +1.71% | -0.90% | +52.13% | +176.27% | 1.41TCr | |
| +4.16% | +4.44% | +444.12% | +183.06% | 1.26TCr | |
| Average | +6.87% | +0.99% | +87.62% | +196.74% | 2.6TCr | |
| Weighted average by Cap. | +3.53% | +1.83% | +60.28% | +147.84% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.13 15.97 14.67 27.74 1.88T 28.05 188.26 73.59 937.88 74.07 72.45 3.11T | - |
| Net income | -3.12Cr -2.71Cr -2.53Cr -2.32Cr -4.39Cr -296.95Cr -4.44Cr -30Cr -12Cr -148.44Cr -12Cr -11Cr -491.86Cr | -3.32Cr -2.88Cr -2.69Cr -2.47Cr -4.67Cr -315.49Cr -4.72Cr -32Cr -12Cr -157.71Cr -12Cr -12Cr -522.56Cr |
| Net Debt | -29.9 -25.97 -24.21 -22.24 -42.06 -2.84T -42.52 -285.43 -111.58 -1.42T -112.3 -109.84 -4.71T | 2.37 2.06 1.92 1.76 3.33 225.54 3.37 22.63 8.85 112.74 8.9 8.71 373.56 |
Employees
-
